Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia): a hypothesis.
Sandyk R, Kay SR.
Funct Neurol. 1990 Apr-Jun;5(2):165-70.
Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases.
Tolosa ES.
Arch Neurol. 1981 Mar;38(3):147-51. doi: 10.1001/archneur.1981.00510030041005.
Essential blepharospasm and related dystonias.
Jordan DR, Patrinely JR, Anderson RL, Thiese SM.
Surv Ophthalmol. 1989 Sep-Oct;34(2):123-32. doi: 10.1016/0039-6257(89)90040-4.
Brain Calcification and Movement Disorders.
Kostić VS, Petrović IN.
Curr Neurol Neurosci Rep. 2017 Jan;17(1):2. doi: 10.1007/s11910-017-0710-9.
Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
Tolosa E, Martí MJ.
Adv Neurol. 1988;49:73-84.
Should the Globus Pallidus Targeting Be Refined in Dystonia?
da Silva Lapa JD, Godinho FLF, Teixeira MJ, Listik C, Iglesio RF, Duarte KP, Cury RG.
J Neurol Surg A Cent Eur Neurosurg. 2022 Jul;83(4):361-367. doi: 10.1055/s-0041-1735856. Epub 2021 Nov 22.
Dental implications of some common movement disorders: a concise review.
Lobbezoo F, Naeije M.
Arch Oral Biol. 2007 Apr;52(4):395-8. doi: 10.1016/j.archoralbio.2006.09.005. Epub 2006 Nov 27.
Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic orofacial dystonia).
Brennan MJ, Ruff P, Sandyk R.
Br Med J (Clin Res Ed). 1982 Sep 25;285(6345):853. doi: 10.1136/bmj.285.6345.853.
Botulinum toxin modulates basal ganglia but not deficient somatosensory activation in orofacial dystonia.
Dresel C, Bayer F, Castrop F, Rimpau C, Zimmer C, Haslinger B.
Mov Disord. 2011 Jul;26(8):1496-502. doi: 10.1002/mds.23497. Epub 2011 May 20.
[Oral symptoms of immunologic disorders. Part I. Systemic autoimmune diseases].
Márton K.
Fogorv Sz. 2003 Feb;96(1):9-15.
